Stella Diagnostics

SLDX

Medical - Diagnostics & Research · Healthcare

Price

$0.01

+0.00 (+0.00%)

Market Cap

$497,509

Winston Score

–

No score yet — Winston is napping.

We couldn’t gather enough financial data to score this stock reliably.

Share count rising — dilution

+259.0% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 96.4M (2021) → 346.0M (2025)

Stella Diagnostics is a small medical company that makes tools to help doctors detect and monitor diseases in the body. Its core focus is on diagnostic devices designed to identify conditions early, with hospitals and clinical settings as its primary customers. The company operates in the medical diagnostics industry, which is highly competitive and heavily regulated by agencies like the FDA.

Stella Diagnostics generates revenue by selling its diagnostic products and related services to healthcare providers. It is a very small company, with a market cap near zero, and it is currently losing money — its operating margin is deeply negative, meaning it spends far more than it earns. The company faces significant financial risk, as negative gross margins indicate it costs more to deliver its products than it charges for them, and it will need to either raise additional capital or dramatically grow sales to reach profitability.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

Revenue data limited

EPS Growth

-783.3% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

77.8%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~0 months

$58,007 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Cash watch

Stella Diagnostics has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

-17.0%

Thin — -17.0% gross margin

Operating Margin

-314.9%

Losing money on operations — -314.9%

ROCE

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

N/A

—

Data not available

EPS YoY

N/A

—

Data not available

EPS Consistency

0/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

—

Data not available

FCF Margin

-72.9%

Burning cash (-72.9%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

—

Data not available

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

—

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial